Tabid, Cyruz .

HRN: 22-63-05  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/29/2023
CEFUROXIME 750MG (VIAL)
08/29/2023
09/04/2023
IVT
275mg
Q8
PCAP
Waiting Final Action 
09/01/2023
CLARITHROMYCIN 125MG/5ML, 60ML SUSPENSION (BOT)
09/01/2023
09/07/2023
PO
2.5
BID
Pcapc
Waiting Final Action 
09/02/2023
CEFTRIAXONE 1G (VIAL)
09/02/2023
09/08/2023
IV
820mg
OD
Pcap C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: